Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses

BACKGROUND: Ulcerative colitis (UC) is an inflammatory disease of the colon and rectum. Treatment options include biologics and tofacitinib. OBJECTIVES: We aim to summarize the evidence on efficacy and safety of biologics and tofacitinib in moderate-to-severe UC. METHODS: PubMed, Embase, Scopus, and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:United European Gastroenterol J
Auteurs principaux: Pantavou, Katerina, Yiallourou, Anneza I, Piovani, Daniele, Evripidou, Despo, Danese, Silvio, Peyrin-Biroulet, Laurent, Bonovas, Stefanos, Nikolopoulos, Georgios K
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2019
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894001/
https://ncbi.nlm.nih.gov/pubmed/31839954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619883566
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires